Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.36
-0.09 (-1.40%)
At close: Nov 20, 2024, 4:00 PM
6.33
-0.03 (-0.47%)
After-hours: Nov 20, 2024, 7:54 PM EST
Company Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.
Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Ginkgo Bioworks Holdings, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,218 |
| CEO | Jason Kelly |
Contact Details
Address: 27 Drydock Avenue, 8th Floor Boston, Massachusetts 02210 United States | |
| Phone | 877 422 5362 |
| Website | ginkgobioworks.com |
Stock Details
| Ticker Symbol | DNA |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001830214 |
| CUSIP Number | 37611X100 |
| ISIN Number | US37611X1000 |
| Employer ID | 87-2652913 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Reshma P. Shetty | Founder, President, Chief Operating Officer and Director |
| Mark E. Dmytruk | Chief Financial Officer |
| Thomas Knight Jr. | Founder |
| Austin Che Ph.D. | Founder, Head of Strategy and Treasurer |
| Steven P. Coen CPA | Chief Accounting Officer |
| Karen Tepichin | General Counsel and Secretary |
| Anna Marie Wagner M.B.A. | Senior Vice President of Corporate Development |
| Samantha Sutton | Head of People |
| Joshua Dunn | Head of Design |
| Joaquim Marques | Head of Omics and Analytical Chemistry |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 20, 2024 | 144 | Filing |
| Nov 19, 2024 | 144 | Filing |
| Nov 18, 2024 | 144 | Filing |
| Nov 15, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | 144 | Filing |
| Nov 13, 2024 | 144 | Filing |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |